SBIR/STTR Research Award

Tricalcium Phosphate for Orthopedic Applications

Award identifier 5003fde59feb5bd26006fb3cc9cb6e4024aa1ef919f984b60d7d229437ba44b4Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$161,595

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Angstrom Medica, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Titanium and resorbable polymers are the materials of choice when reattaching the ACL with an interference screw. While titanium screws possess sufficient strength to withstand insertion and the holding power to retain the ACL in the bone, tearing of the ACL and difficulty in removing the screw during revision have motivated the development of resorbable polymer ACL screws. However, polymer screws often break during insertion or once implanted and result in intra-articular bodies in the knee joint and the potential for "locking knees." Metal and polymer materials result in the formation of fibrous scar tissue around the implantation and prevent tissue bonding. Metallic screws have been associated with chronic pain, tenderness and bone atrophy at the implantation site and polymeric implants and their degradation by- products have resulted in multiple complications. Consequently, there is a need for an ACL interference screw that bonds to bone without scar tissue formation and that resorbs without any associated morbidities. Tricalcium phosphate (TCP) has the ability to be resorbed in vivo and be replaced by the ingrowth of natural bone in vivo. However, conventionally processed TCP materials have poor mechanical properties. Using proprietary nanostructure processing of TCP, crystallinity and stoichiometry as well as particle size and morphology can be controlled to produce superior mechanical strengths and improved in vitro and in vivo bioactivity. In this application, the objectives are focused on producing dense nanocrystalline TCP (nTCP) and testing this material to confirm that nTCP confers both mechanical strength and biocompatibility advantages for its use in soft tissue and bone fixation applications. While many nanotechnology applications still remain several years away from commercialization, this project will demonstrate a successful translation of nanotechnology into a superior product for the marketplace and demonstrate that nanotechnology can be used to imbue common materials with exceptional properties.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.